| Literature DB >> 26635531 |
Marie C M Halliez1, André G Buret2.
Abstract
Gastrointestinal motility and transport of water and electrolytes play key roles in the pathophysiology of diarrhea upon exposure to enteric parasites. These processes are actively modulated by the enteric nervous system (ENS), which includes efferent, and afferent neurons, as well as interneurons. ENS integrity is essential to the maintenance of homeostatic gut responses. A number of gastrointestinal parasites are known to cause disease by altering the ENS. The mechanisms remain incompletely understood. Cryptosporidium parvum, Giardia duodenalis (syn. Giardia intestinalis, Giardia lamblia), Trypanosoma cruzi, Schistosoma species and others alter gastrointestinal motility, absorption, or secretion at least in part via effects on the ENS. Recent findings also implicate enteric parasites such as C. parvum and G. duodenalis in the development of post-infectious complications such as irritable bowel syndrome, which further underscores their effects on the gut-brain axis. This article critically reviews recent advances and the current state of knowledge on the impact of enteric parasitism on the neural control of gut functions, and provides insights into mechanisms underlying these abnormalities.Entities:
Keywords: absorption; enteric nervous system; gastrointestinal parasites; intestinal functions; motility; neuroregulation; secretion
Year: 2015 PMID: 26635531 PMCID: PMC4658430 DOI: 10.3389/fncel.2015.00452
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
This table provides an update on how enteric parasites may alter neuro-regulation pathway in the gut, and lists the physiological consequences that have been associated with these changes.
| Parasite | Physiological modifications | Neuroregulating factors involved | References |
|---|---|---|---|
| Altered ion transport | – Prostaglandins (PGE2) | ||
| – Prostacyclins (PGI2) via cholinergic and VIPergic nerves | |||
| Malabsorption/Hypersecretion | – Increased levels of Substance P | ||
| Altered intestinal contractility/motility | – Nitric Oxide depletion by | ||
| – Reduced 5-HT | |||
| – Increased CCK trigerred by mast cell | |||
| Malabsorption/Hypersecretion | – Increased intestinal transit, reduction in villus and microvillus areas | ||
| Hypersensitivity | – Correlation with | ||
| – Role for mast cells | |||
| Neurons and axons degradation | – Cysteine-protease dependent degradation | ||
| Motility dysfunctions | – Correlation with reduced | ||
| – Inflammatory mediators influence | |||
| – CCK action via CCK-A, CCK-B, cholinergic stimulation and vagal afferent pathway | |||
| – IL-4Rα-activated Stat 6 dependent mechanism | |||
| Nerve remodeling | – Mucosal nerves degeneration during the acute phase of inflammation in correlation with mast cell degranulation | ||
| – Reinnervation after parasite expulsion | |||
| Impaired fluid transport | – Probably linked to mast cell products action on ENS | ||
| Chemo-/Mechanosensitivity | – Permeability changes/alteration in excitability of intrinsic neuronal reflexes | ||
| – Sensitization of vagal afferent neurons | |||
| – Alteration of genes profile of the vagal pathway involved in chemosensitivity | |||
| – Decreased 5-HT3A receptor | |||
| – Correlation with mast cell hyperplasia | |||
| – Dependent on tachykinin NK2 receptor | |||
| Altered intestinal contractility | – Muscle hypertrophy and hyperplasia | ||
| – Mastocytosis | |||
| – Altered neurotransmitter release (SP modulates GI inflammation, decreased NK1 immunoreactivity, pro-inflammatory cytokines production) | |||
| – Altered 5-HT receptor function | |||
| – role for T-lymphocytes | |||
| Altered intestinal contractility | – Integrity of the ENS necessary as sensors along the intestine initiate its activity | ||
| Altered ion transport | – Affected by histamine | ||
| – Role for neurotransmitters (SP, CGRP) | |||
| Altered intestinal contractility | – Direct effect via smooth muscle cell activation | ||
| – Indirect effect through activation of neuronal nicotinic receptors and alteration of myenteric plexus | |||
| – Role for mast cells, pro-inflammatory cytokines and prostaglandins | |||
| – Impairment of purinergic control of enteric cholinergic neurotransmission | |||
| – SST receptor upregulation | |||
| Increased intestinal muscle thickness | – Diffuse mucosal inflammation due to granulomas | ||
| – Role for mast cells | |||
| Denervation/Decrease of enteric glial cells | – Loss of tolerance to self antigen | ||
| – Cross reaction between parasite released antigens and host antigens (parasite antigens mimics hosts antigens) | |||
| – Neurolysis due to neurotoxin-like substance released by disintegrating amastigote upon pseudocyst rupture | |||
| – High NO levels and iNOS activation | |||
| – Host immune response | |||
| Hypersensitivity | – Decreased responsiveness of smooth muscle to ACh and consequently reduced contractive capabilities | ||
| Quantitative and phenotypic changes in neurons | – NO production by parasite-induced IFN- | ||
| – Parasite detrimental effect on mitochondria |